NeuroBo Pharmaceuticals Inc (NRBO)
2.27
-0.12
(-5.02%)
USD |
NASDAQ |
Nov 15, 12:53
NeuroBo Pharmaceuticals Free Cash Flow: -22.69M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -22.69M |
| June 30, 2024 | -19.95M |
| March 31, 2024 | -14.74M |
| December 31, 2023 | -10.85M |
| September 30, 2023 | -9.254M |
| June 30, 2023 | -8.762M |
| March 31, 2023 | -9.434M |
| December 31, 2022 | -11.71M |
| September 30, 2022 | -12.80M |
| June 30, 2022 | -12.95M |
| March 31, 2022 | -13.82M |
| December 31, 2021 | -15.14M |
| September 30, 2021 | -14.59M |
| June 30, 2021 | -14.04M |
| March 31, 2021 | -12.77M |
| December 31, 2020 | -10.77M |
| September 30, 2020 | -9.792M |
| June 30, 2020 | -11.28M |
| Date | Value |
|---|---|
| March 31, 2020 | -10.17M |
| December 31, 2019 | -7.039M |
| September 30, 2019 | -2.414M |
| June 30, 2019 | -3.353M |
| March 31, 2019 | -8.439M |
| December 31, 2018 | -14.45M |
| September 30, 2018 | -24.56M |
| June 30, 2018 | -27.57M |
| March 31, 2018 | -27.91M |
| December 31, 2017 | -26.90M |
| September 30, 2017 | -23.76M |
| June 30, 2017 | -20.10M |
| March 31, 2017 | -15.21M |
| December 31, 2016 | -11.04M |
| September 30, 2016 | -9.676M |
| June 30, 2016 | -7.604M |
| March 31, 2016 | -6.869M |
| December 31, 2015 | -5.433M |
Free Cash Flow Range, Past 5 Years
-22.69M
Minimum
Sep 2024
-7.039M
Maximum
Dec 2019
-12.63M
Average
-12.24M
Median
Free Cash Flow Benchmarks
| Cytokinetics Inc | -407.05M |
| Ocugen Inc | -54.47M |
| enVVeno Medical Corp | -16.74M |
| Scholar Rock Holding Corp | -168.65M |
| Mirum Pharmaceuticals Inc | -39.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.589M |
| Cash from Financing (Quarterly) | -0.676M |
| Free Cash Flow Per Share (Quarterly) | -0.5472 |
| Free Cash Flow Yield | -154.8% |